Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 343

1.

Early inhibitory effects of zoledronic acid in tooth extraction sockets in dogs are negated by recombinant human bone morphogenetic protein.

Gerard DA, Carlson ER, Gotcher JE, Pickett DO.

J Oral Maxillofac Surg. 2014 Jan;72(1):61-6. doi: 10.1016/j.joms.2013.06.192. Epub 2013 Jul 25.

PMID:
23891015
2.

Effects of short-term zoledronic acid treatment on bone remodeling and healing at surgical sites in the maxilla and mandible of aged dogs.

Huja SS, Mason A, Fenell CE, Mo X, Hueni S, D'Atri AM, Fernandez SA.

J Oral Maxillofac Surg. 2011 Feb;69(2):418-27. doi: 10.1016/j.joms.2010.05.062. Epub 2010 Dec 3.

PMID:
21122971
3.

Matrix metalloproteinase-9 expression in alveolar extraction sockets of Zoledronic acid-treated rats.

Basi DL, Hughes PJ, Thumbigere-Math V, Sabino M, Mariash A, Lunos SA, Jensen E, Gopalakrishnan R.

J Oral Maxillofac Surg. 2011 Nov;69(11):2698-707. doi: 10.1016/j.joms.2011.02.065. Epub 2011 Jul 12.

PMID:
21752506
4.

Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog.

Barboza EP, Duarte ME, Geolás L, Sorensen RG, Riedel GE, Wikesjö UM.

J Periodontol. 2000 Mar;71(3):488-96.

PMID:
10776939
5.

Impact of recombinant human bone morphogenetic protein-2 on residual ridge resorption after tooth extraction: an experimental study in the rat.

Matin K, Nakamura H, Irie K, Ozawa H, Ejiri S.

Int J Oral Maxillofac Implants. 2001 May-Jun;16(3):400-11.

PMID:
11432660
6.

Evaluation of a compression resistant matrix for recombinant human bone morphogenetic protein-2.

Lu SX, Fiorini T, Lee J, Prasad HS, Buxton AN, Bisch FC, Dixon DR, Susin C, Wikesjö UM.

J Clin Periodontol. 2013 Jul;40(7):688-97. doi: 10.1111/jcpe.12109. Epub 2013 Apr 30.

PMID:
23627347
7.

The effect of systemically administered bisphosphonates on bony healing after tooth extraction and osseointegration of dental implants in the rabbit maxilla.

Kim I, Ki H, Lee W, Kim H, Park JB.

Int J Oral Maxillofac Implants. 2013 Sep-Oct;28(5):1194-200. doi: 10.11607/jomi.2685.

PMID:
24066308
8.

Collagen sponge and rhBMP-2 improve socket healing in rats treated with zoledronic acid.

Oh JS, Kim SG.

Braz Oral Res. 2017 Dec 7;31:e99. doi: 10.1590/1807-3107bor-2017.vol31.0099.

9.

Parathyroid hormone related to bone regeneration in grafted and nongrafted tooth extraction sockets in rats.

Kuroshima S, Al-Salihi Z, Yamashita J.

Implant Dent. 2013 Feb;22(1):71-6. doi: 10.1097/ID.0b013e318278f94d.

PMID:
23296032
10.

Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

Ersan N, van Ruijven LJ, Bronckers AL, Olgaç V, Ilgüy D, Everts V.

Dentomaxillofac Radiol. 2014;43(1):20130144. doi: 10.1259/dmfr.20130144. Epub 2013 Oct 29.

11.

Buccal bone formation after flapless extraction: a randomized, controlled clinical trial comparing recombinant human bone morphogenetic protein 2/absorbable collagen carrier and collagen sponge alone.

Coomes AM, Mealey BL, Huynh-Ba G, Barboza-Arguello C, Moore WS, Cochran DL.

J Periodontol. 2014 Apr;85(4):525-35. doi: 10.1902/jop.2013.130207. Epub 2013 Jul 4.

PMID:
23826643
12.

Ridge regeneration of damaged extraction sockets using rhBMP-2: an experimental study in canine.

Lee JS, Jung JS, Im GI, Kim BS, Cho KS, Kim CS.

J Clin Periodontol. 2015 Jul;42(7):678-87. doi: 10.1111/jcpe.12414. Epub 2015 Jun 8.

PMID:
25946650
13.

Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation.

Fiorellini JP, Howell TH, Cochran D, Malmquist J, Lilly LC, Spagnoli D, Toljanic J, Jones A, Nevins M.

J Periodontol. 2005 Apr;76(4):605-13.

PMID:
15857102
14.

The inhibitory effect of zoledronate on early-stage osteoinduction by recombinant human bone morphogenetic protein 2 in an osteoporosis model.

Lee JH, Baek HR, Lee KM, Zheng GB, Shin SJ, Jin YZ.

Growth Factors. 2015;33(3):220-8. doi: 10.3109/08977194.2015.1058259. Epub 2015 Jun 23.

PMID:
26099999
15.

Effect of zoledronic acid on bone healing subsequent to mini-implant insertion.

Huja SS, Kaya B, Mo X, D'Atri AM, Fernandez SA.

Angle Orthod. 2011 May;81(3):363-9. doi: 10.2319/070710-384.1. Epub 2011 Jan 24.

PMID:
21261489
16.
17.
18.

Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.

McDonald MM, Dulai S, Godfrey C, Amanat N, Sztynda T, Little DG.

Bone. 2008 Oct;43(4):653-62. doi: 10.1016/j.bone.2008.05.019. Epub 2008 Jun 3.

PMID:
18582604
19.

Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: a comparison of rhBMP-2, cancellous bone graft, and absorbable collagen sponge.

Zabka AG, Pluhar GE, Edwards RB 3rd, Manley PA, Hayashi K, Heiner JP, Kalscheur VL, Seeherman HJ, Markel.

J Orthop Res. 2001 Mar;19(2):318-27. Erratum in: J Orthop Res 2001 Sep;19(5):990.

20.

Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.

Little DG, McDonald M, Bransford R, Godfrey CB, Amanat N.

J Bone Miner Res. 2005 Nov;20(11):2044-52. Epub 2005 Jul 18.

Supplemental Content

Support Center